Omid Moghadam

Omid Moghadam has a diverse work experience, including roles as Chief Executive Officer at Namida Lab, Inc. since June 2019, Chairman and Co-Founder at Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) since January 2018, and Entrepreneur In Residence at the University of California at Los Angeles since April 2015. Omid also served as CEO and Chairman at Ascendant Diagnostics from March 2013 to May 2019, and as Chairman of the Board at CardioWise, Inc. from February 2011 to May 2019. Additionally, Omid has held positions on the board of directors at The Diary Pte. Ltd., Osteovantage, Best Shot Foundation, and Healthe Care Australia. Omid conducted personal genomics research at Harvard Medical School from October 2008 to March 2010.

Omid Moghadam completed their education history by first earning a Bachelor of Science degree in Electrical and Computer Engineering from the University at Buffalo in 1989. Omid then pursued a Master of Science degree in Electrical Engineering from the same university, which they completed in 1991. Later on, Omid pursued further education and obtained an MBA degree in Finance from the University of Rochester - Simon Business School between 1995 and 1997.